share_log

新銳醫藥：截至2024年1月31日之股份發行人的證券變動月報表

NEW RAY MEDIC: MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 JANUARY 2024

香港交易所 ·  Feb 1 04:03
Summary by Moomoo AI
新銳醫藥國際控股有限公司（新銳醫藥）於2024年1月31日提交了最新的證券變動月報表。報告顯示，截至2024年1月底，公司的法定/註冊股本維持在3,000,000,000股，每股面值0.05港元，總股本為150,000,000港元，與上月相比無變動。已發行股份數目亦保持在1,671,846,657股。此外，根據2013年10月25日採納的股份期權計劃，本月底結存的股份期權數目為143,200,000，本月內無變動，且本月內無因行使期權而得到的資金。公司秘書吳日升確認，所有證券的發行均已獲得董事會批准，並符合香港聯合交易所有限公司證券上市規則的相關要求。
新銳醫藥國際控股有限公司（新銳醫藥）於2024年1月31日提交了最新的證券變動月報表。報告顯示，截至2024年1月底，公司的法定/註冊股本維持在3,000,000,000股，每股面值0.05港元，總股本為150,000,000港元，與上月相比無變動。已發行股份數目亦保持在1,671,846,657股。此外，根據2013年10月25日採納的股份期權計劃，本月底結存的股份期權數目為143,200,000，本月內無變動，且本月內無因行使期權而得到的資金。公司秘書吳日升確認，所有證券的發行均已獲得董事會批准，並符合香港聯合交易所有限公司證券上市規則的相關要求。
XINYUI PHARMACEUTICALS INTERNATIONAL HOLDINGS LIMITED (XINHUI PHARMACEUTICALS) FILED ITS LATEST MONTHLY STATEMENT OF SECURITIES CHANGES ON JANUARY 31, 2024. The report shows that as of the end of January 2024, the company's regulated/registered share capital remained at 3,000,000,000 shares with a face value of HK$0.05 per share and a total share capital of HK$150,000,000, unchanged from the previous month. The number of issued shares also remained at 1,671,846,657 shares. In addition, under the share option plan adopted on 25 October 2013, the number of stock options outstanding at the end of the month was 143,200,000, unchanged during the month and no funds received during the month as a result of the exercise of the options. Company Secretary Wu Zhisheng confirmed that all issuance of securities has been approved by the Board of Directors and complies with the relevant requirements of the Securities Listing Rules of the Hong Kong Stock Exchange Limited.
XINYUI PHARMACEUTICALS INTERNATIONAL HOLDINGS LIMITED (XINHUI PHARMACEUTICALS) FILED ITS LATEST MONTHLY STATEMENT OF SECURITIES CHANGES ON JANUARY 31, 2024. The report shows that as of the end of January 2024, the company's regulated/registered share capital remained at 3,000,000,000 shares with a face value of HK$0.05 per share and a total share capital of HK$150,000,000, unchanged from the previous month. The number of issued shares also remained at 1,671,846,657 shares. In addition, under the share option plan adopted on 25 October 2013, the number of stock options outstanding at the end of the month was 143,200,000, unchanged during the month and no funds received during the month as a result of the exercise of the options. Company Secretary Wu Zhisheng confirmed that all issuance of securities has been approved by the Board of Directors and complies with the relevant requirements of the Securities Listing Rules of the Hong Kong Stock Exchange Limited.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more